Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (47)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nikolic-Paterson, D. J.
Right arrow Articles by C. Atkins, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nikolic-Paterson, D. J.
Right arrow Articles by C. Atkins, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 3-7
© 2001 European Renal Association-European Dialysis and Transplant Association



The role of macrophages in glomerulonephritis

David J. Nikolic-Paterson and Robert C. Atkins

Department of Nephrology and Monash University Department of Medicine, Monash Medical Centre, Clayton, Australia

Abstract

Macrophage accumulation is a prominent feature in most types of human glomerulonephritis. In particular, tubulointerstitial macrophage accumulation correlates with the degree of renal dysfunction and is predictive of disease progression. Depletion studies have shown that macrophages can induce glomerular injury in experimental glomerulonephritis. Moreover, recent studies targeting chemokines and adhesion molecules have shown that inhibiting macrophage accumulation can suppress progressive renal injury in animal models of glomerulonephritis. Macrophages can produce many molecules with the potential to cause renal damage, although the precise mechanism(s) of macrophage-mediated renal injury have yet to be determined. It is now evident that tubules—a major source of chemokines and adhesion molecules—play an active role in promoting interstitial macrophage infiltration and activation. Thus, targeting pro-inflammatory functions of tubular epithelial cells may be an effective means to inhibit macrophage-mediated tubulointerstitial injury without causing systemic immunosuppression.

Keywords: adhesion molecules; cytokines; glomerulonephritis; macrophages; M-CSF; tubules

Notes

Correspondence and offprint requests to: Robert C. Atkins, Department of Nephrology, Monash Medical Centre, Clayton Road, Clayton, Victoria 3168, Australia.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. J. Li, S. H. Lee, D. K. Kim, R. Jin, D.-S. Jung, S.-J. Kwak, S. H. Kim, S. H. Han, J. E. Lee, S. J. Moon, et al.
Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy
Am J Physiol Renal Physiol, July 1, 2009; 297(1): F200 - F209.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Arakawa, T. Masaki, T. Hirai, S. Doi, M. Kuratsune, K. Arihiro, N. Kohno, and N. Yorioka
Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3418 - 3426.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Okamura, Y. Takano, N. Hiramatsu, K. Hayakawa, J. Yao, A. W. Paton, J. C. Paton, and M. Kitamura
Suppression of cytokine responses by indomethacin in podocytes: a mechanism through induction of unfolded protein response
Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1495 - F1503.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. A. Pozdzik, I. J. Salmon, C. P. Husson, C. Decaestecker, E. Rogier, M.-F. Bourgeade, M. M. Deschodt-Lanckman, J.-L. Vanherweghem, and J. L. Nortier
Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2480 - 2491.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. S. Awad, L. Huang, H. Ye, E. T. A. Duong, W. K. Bolton, J. Linden, and M. D. Okusa
Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy
Am J Physiol Renal Physiol, April 1, 2006; 290(4): F828 - F837.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
R. Waltzman, C. Croot, G. R. Justice, M. R. Fesen, V. Charu, and D. Williams
Randomized Comparison of Epoetin Alfa (40,000 U Weekly) and Darbepoetin Alfa (200 {micro}g Every 2 Weeks) in Anemic Patients with Cancer Receiving Chemotherapy
Oncologist, September 1, 2005; 10(8): 642 - 650.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. B. Corlin, J. W. Sen, S. Ladefoged, G. B. Lund, M. H. Nissen, and N. H.H. Heegaard
Quantification of Cleaved {beta}2-Microglobulin in Serum from Patients Undergoing Chronic Hemodialysis
Clin. Chem., July 1, 2005; 51(7): 1177 - 1184.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Gong, A. Rifai, E. M. Tolbert, P. Biswas, J. N. Centracchio, and L. D. Dworkin
Hepatocyte Growth Factor Ameliorates Renal Interstitial Inflammation in Rat Remnant Kidney by Modulating Tubular Expression of Macrophage Chemoattractant Protein-1 and RANTES
J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2868 - 2881.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
F. Farrell and A. Lee
The Erythropoietin Receptor and Its Expression in Tumor Cells and Other Tissues
Oncologist, November 1, 2004; 9(suppl_5): 18 - 30.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Kanellis, G. E. Garcia, P. Li, G. Parra, C. B. Wilson, Y. Rao, S. Han, C. W. Smith, R. J. Johnson, J. Y. Wu, et al.
Modulation of Inflammation by Slit Protein In Vivo in Experimental Crescentic Glomerulonephritis
Am. J. Pathol., July 1, 2004; 165(1): 341 - 352.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. M. Tarzi, H. T. Cook, I. Jackson, C. D. Pusey, and G. M. Lord
Leptin-Deficient Mice Are Protected from Accelerated Nephrotoxic Nephritis
Am. J. Pathol., February 1, 2004; 164(2): 385 - 390.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. T. Jurkovitz, J. L. Abramson, L. V. Vaccarino, W. S. Weintraub, and W. M. McClellan
Association of High Serum Creatinine and Anemia Increases the Risk of Coronary Events: Results from the Prospective Community-Based Atherosclerosis Risk in Communities (ARIC) Study
J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2919 - 2925.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H.-J. Anders, B. Banas, Y. Linde, L. Weller, C. D. Cohen, M. Kretzler, S. Martin, V. Vielhauer, D. Schlondorff, and H.-J. Grone
Bacterial CpG-DNA Aggravates Immune Complex Glomerulonephritis: Role of TLR9-Mediated Expression of Chemokines and Chemokine Receptors
J. Am. Soc. Nephrol., February 1, 2003; 14(2): 317 - 326.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.